- FFR is reasonable to assess angiographic intermediate coronary lesions (50-70% diameter stenosis) and can be useful for guiding revascularization decisions in patients with stable ischemic heart disease (SIHD). (Class lla, Level of Evidence A).
CathWorks Announces Appointment of Ramin Mousavi as Chief Executive Officer and Board Member
- Jun 14, 2021
CathWorks Announces $30 Million in New Financing
- Jan 08, 2021
CathWorks FFRangio™ System Receives Regulatory Approval in Japan
- Dec 11, 2019